J M Smucker Co (NYSE:SJM) Given Consensus Rating of “Hold” by Brokerages

Share on StockTwits

J M Smucker Co (NYSE:SJM) has earned a consensus recommendation of “Hold” from the twelve analysts that are covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a sell recommendation, six have given a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $113.38.

A number of equities research analysts have recently issued reports on the company. Stifel Nicolaus dropped their price objective on J M Smucker from $120.00 to $110.00 and set a “hold” rating on the stock in a research note on Wednesday, August 28th. Credit Suisse Group cut shares of J M Smucker from a “neutral” rating to an “underperform” rating and decreased their target price for the company from $100.00 to $95.00 in a research note on Wednesday, November 13th. Citigroup lowered their target price on shares of J M Smucker from $142.00 to $132.00 and set a “buy” rating on the stock in a report on Thursday, August 29th. ValuEngine raised shares of J M Smucker from a “strong sell” rating to a “sell” rating in a research report on Thursday, October 10th. Finally, Guggenheim cut their price target on shares of J M Smucker from $99.00 to $93.00 and set a “sell” rating for the company in a research note on Wednesday, August 28th.

Shares of J M Smucker stock traded down $0.40 during trading hours on Tuesday, reaching $105.30. 22,347 shares of the company’s stock were exchanged, compared to its average volume of 1,052,823. The stock has a market cap of $11.99 billion, a P/E ratio of 12.70, a P/E/G ratio of 3.99 and a beta of 0.41. The company has a 50 day moving average of $106.59 and a two-hundred day moving average of $112.76. The company has a current ratio of 0.72, a quick ratio of 0.28 and a debt-to-equity ratio of 0.58. J M Smucker has a fifty-two week low of $91.32 and a fifty-two week high of $128.43.

J M Smucker (NYSE:SJM) last released its earnings results on Friday, November 22nd. The company reported $2.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.13 by $0.13. J M Smucker had a return on equity of 11.60% and a net margin of 7.30%. The business had revenue of $1.96 billion for the quarter, compared to the consensus estimate of $1.97 billion. During the same quarter in the previous year, the business earned $2.17 earnings per share. J M Smucker’s quarterly revenue was down 3.2% on a year-over-year basis. As a group, analysts expect that J M Smucker will post 8.15 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Monday, December 2nd. Investors of record on Friday, November 15th were paid a $0.88 dividend. This represents a $3.52 dividend on an annualized basis and a yield of 3.34%. The ex-dividend date of this dividend was Thursday, November 14th. J M Smucker’s dividend payout ratio (DPR) is presently 42.46%.

In other J M Smucker news, CFO Mark R. Belgya sold 750 shares of the company’s stock in a transaction on Monday, September 30th. The shares were sold at an average price of $110.00, for a total value of $82,500.00. Following the transaction, the chief financial officer now directly owns 53,442 shares in the company, valued at $5,878,620. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Kevin G. Jackson sold 487 shares of the stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $108.70, for a total transaction of $52,936.90. The disclosure for this sale can be found here. Insiders have sold a total of 1,987 shares of company stock valued at $217,937 in the last ninety days. Insiders own 3.70% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. lifted its position in J M Smucker by 2.7% during the second quarter. BlackRock Inc. now owns 9,934,921 shares of the company’s stock worth $1,144,403,000 after acquiring an additional 258,305 shares during the last quarter. Canada Pension Plan Investment Board increased its stake in shares of J M Smucker by 12,607.9% during the second quarter. Canada Pension Plan Investment Board now owns 187,315 shares of the company’s stock worth $21,577,000 after purchasing an additional 185,841 shares during the period. Andra AP fonden lifted its holdings in J M Smucker by 5.2% during the 3rd quarter. Andra AP fonden now owns 48,700 shares of the company’s stock worth $5,358,000 after purchasing an additional 2,400 shares during the last quarter. Trust Co. of Vermont lifted its holdings in J M Smucker by 13.7% during the 2nd quarter. Trust Co. of Vermont now owns 12,114 shares of the company’s stock worth $1,395,000 after purchasing an additional 1,455 shares during the last quarter. Finally, Stephens Inc. AR boosted its stake in J M Smucker by 0.4% in the 2nd quarter. Stephens Inc. AR now owns 22,433 shares of the company’s stock valued at $2,584,000 after purchasing an additional 94 shares during the period. Institutional investors own 78.07% of the company’s stock.

J M Smucker Company Profile

The J. M. Smucker Co engages in the manufacture and marketing of branded food and beverage products. It operates through the following segments: U.S. Retail Coffee, U.S. Retail Consumer Foods, U.S. Retail Pet Foods, and International and Away From Home. The U. S. Retail Coffee segment includes the domestic sales of Folgers, Dunkin Donuts, and Cafe Bustelo branded coffee.

Recommended Story: Elliott Wave Theory

Analyst Recommendations for J M Smucker (NYSE:SJM)

Receive News & Ratings for J M Smucker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for J M Smucker and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.